The study compared 6996 liver transplants from DBD to 567 from DCD donors in patients with similar HCC characteristics, such as alpha-fetoprotein level, tumor size and number, and bridge/downstaging treatments. The gene discussed is AFP; the disease is hepatocellular carcinoma.